Augmedix, Inc.
AUGX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $257 | $58 | $91 | $131 |
| - Cash | $46 | $22 | $42 | $21 |
| + Debt | $26 | $20 | $15 | $15 |
| Enterprise Value | $237 | $56 | $64 | $125 |
| Revenue | $45 | $31 | $22 | $16 |
| % Growth | 45% | 39.6% | 34.5% | – |
| Gross Profit | $22 | $14 | $10 | $7 |
| % Margin | 48% | 45.1% | 45.1% | 41.2% |
| EBITDA | -$16 | -$22 | -$14 | -$13 |
| % Margin | -34.9% | -70.5% | -65.3% | -80.6% |
| Net Income | -$19 | -$27 | -$17 | -$15 |
| % Margin | -42.7% | -85.8% | -77.4% | -89.4% |
| EPS Diluted | -0.44 | -0.71 | -0.59 | -0.55 |
| % Growth | 38% | -20.3% | -7.3% | – |
| Operating Cash Flow | -$15 | -$17 | -$19 | -$14 |
| Capital Expenditures | -$3 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$19 | -$18 | -$19 | -$15 |